Metabolic syndrome prevalence in women with gestational diabetes mellitus in the second trimester of gravidity
Open accessAbstract
Background: Women with gestational diabetes (GDM) have an increased risk of metabolic syndrome (MS) after delivery. MS could precede gravidity. The aims of this study were (i) to detect the prevalence of MS in women at the time of GDM diagnosis, (ii) to detect the prevalence of MS in the subgroup of GDM patients with any form of impaired glucose tolerance after delivery (PGI), and (iii) to determine whether GDM women with MS have a higher risk of peripartal adverse outcomes. Methods: A cross-sectional observational study comprised n = 455 women with GDM. International Diabetes Federation (IDF) criteria for MS definition were modified to the pregnancy situation. Results: MS was detected in 22.6% of GDM patients in those with PGI 40%. The presence of MS in GDM patients was associated with two peripartal outcomes: higher incidence of pathologic Apgar score and macrosomia (p = 0.01 resp. p = 0.0004, chi-square). Conclusions: The presence of MS in GDM patients is a statistically significant risk factor (p = 0.04 chi-square) for PGI. A strong clinical implication of our findings might be to include MS diagnostics within GDM screening using modified MS criteria in the second trimester of pregnancy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metabolic syndrome has been very prevalent among women who have gestational diabetes mellitus, especially in the second trimester of pregnancy.
“Metabolic syndrome has also been very prevalent among women who have GDM, especially in the second trimester of pregnancy (12).”
From Maternal nutritional status and the risk of metabolic syndrome in pregnancy: implications for public health nutrition (2026) · cites this paper as [12]
The Results (§3.1; page unavailable) report metabolic syndrome in 22.6% of women with GDM at 24–28 weeks of pregnancy. The paper studied prevalence in the second trimester but did not compare trimesters, so it does not establish that prevalence is especially high then. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A1C level and future risk of diabetes: a systematic review
Zhang, X., Gregg, E. W., Williamson, D. F., Barker, L. E., Thomas, W., Bullard, K. M., Imperatore, G., Williams, D. E., & Albright, A. L. (2010) · Diabetes Care · doi:10.2337/dc09-1939 · Cited by 422 · see citing works
Intermediate metabolism in normal pregnancy and in gestational diabetes
Di Cianni, G., Miccoli, R., Volpe, L., Lencioni, C., & Del Prato, S. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.390 · Cited by 406 · see citing works
Grieger, J. A., Bianco-Miotto, T., Grzeskowiak, L. E., Leemaqz, S. Y., Poston, L., McCowan, L. M., Kenny, L. C., Myers, J. E., Walker, J. J., Dekker, G. A., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002710 · Cited by 182 · see citing works
Flagged first, then by citations
Research works printed but not linked: 21
- [2]American Diabetes Association Professional Practice Committee 2 Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022 Diabetes Care 2021 45 (Suppl. S1) S17 S38 10.2337/dc22-s002 34964875 · DOI · Paper page
- [3]Keely E. An opportunity not to be missed—How do we improve postpartum screening rates for women with gestational diabetes? Diabetes/Metab. Res. Rev. 2012 28 312 316 10.1002/dmrr.2274 22228674 · DOI
- [4]Bellamy L. Casas J.P. Hingorani A.D. Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis Lancet 2009 373 1773 1779 10.1016/S0140-6736(09)60731-5 19465232 · DOI · Paper page
- [6]Szmuilowicz E.D. Josefson J.L. Metzger B.E. Gestational Diabetes Mellitus Endocrinol. Metab. Clin. N. Am. 2019 48 479 493 10.1016/j.ecl.2019.05.001 PMC7008467 31345518 · DOI · Paper page
- [7]Pathirana M.M. Lassi Z.S. Ali A. Arstall M.A. Roberts C.T. Andraweera P.H. Association between metabolic syndrome and gestational diabetes mellitus in women and their children: A systematic review and meta-analysis Endocrine 2021 71 310 320 10.1007/s12020-020-02492-1 32930949 · DOI
- [9]Alberti K.G. Zimmet P. Shaw J. Metabolic syndrome—A new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet. Med. 2006 23 469 480 10.1111/j.1464-5491.2006.01858.x 16681555 · DOI · Paper page
- [10]Alberti K.G. Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet. Med. 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693 · DOI
- [11]Torgersen K.L. Curran C.A. A systematic approach to the physiologic adaptations of pregnancy Crit. Care Nurs. Q. 2006 29 2 19 10.1097/00002727-200601000-00002 16456359 · DOI
- [12]Macdonald-Wallis C. Lawlor D.A. Fraser A. May M. Nelson S.M. Tilling K. Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies Hypertension 2012 59 1241 1248 10.1161/HYPERTENSIONAHA.111.187039 22526257 PMC3378662 · DOI
- [13]Oostvogels A.J.J.M. Busschers W.B. Spierings E.J.M. Roseboom T.J. Gademan M.G.J. Vrijkotte T.G.M. Pre-pregnancy weight status, early pregnancy lipid profile and blood pressure course during pregnancy: The ABCD study PLoS ONE 2017 12 e0177554 10.1371/journal.pone.0177554 28542294 PMC5438136 · DOI
- [14]Ryckman K.K. Spracklen C.N. Smith C.J. Robinson J.G. Saftlas A.F. Maternal lipid levels during pregnancy and gestational diabetes: A systematic review and meta-analysis BJOG Int. J. Obstet. Gynaecol. 2015 122 643 651 10.1111/1471-0528.13261 25612005 · DOI
- [15]De Long E.R. De Long D.M. Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach Biometrics 1988 44 837 845 10.2307/2531595 3203132 · DOI · Paper page
- [16]Youden W.J. Index for rating diagnostic tests Cancer 1950 3 32 35 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3 15405679 · DOI
- [17]Urbanová J. Brunerová L. Nunes M.A. Brož J. MODY diabetes and screening of gestational diabetes Ceská Gynekol. 2020 85 124 130 32527107
- [18]Chen L.-W. E Soh S. Tint M.-T. Loy S.L. Yap F. Tan K.H. Lee Y.S. Shek L.P.-C. Godfrey K.M. Gluckman P.D. Combined analysis of gestational diabetes and maternal weight status from pre-pregnancy through post-delivery in future development of type 2 diabetes Sci. Rep. 2021 11 5021 10.1038/s41598-021-82789-x 33658531 PMC7930020 · DOI
- [19]Wang C. Zhu W. Wei Y. Su R. Feng H. Hadar E. Hod M. Yang H. The associations between early pregnancy lipid profiles and pregnancy outcomes J. Perinatol. 2017 37 127 133 10.1038/jp.2016.191 27787507 · DOI
- [20]Cibickova L. Schovanek J. Karasek D. Changes in serum lipid levels during pregnancy in women with gestational diabetes. A narrative review Biomed. Pap. Med. Fac. Palacky Univ. Olomouc 2021 165 8 12 10.5507/bp.2021.009 33500589 · DOI
- [21]Zhu S.M. Zhang H.Q. Li C. Zhang C. Yu J.L. Wu Y.T. Huang H.F. Maternal lipid profile during early pregnancy and birth weight: A retrospective study Front. Endocrinol. 2022 13 951871 10.3389/fendo.2022.951871 PMC9521310 36187100 · DOI
- [23]Wani K. Sabico S. Alnaami A.M. Al-Musharaf S. Fouda M.A. Turkestani I.Z. Al-Ajlan A. Alshingetti N.M. Alokail M.S. Al-Daghri N.M. Early-Pregnancy Metabolic Syndrome and Subsequent Incidence in Gestational Diabetes Mellitus in Arab Women Front. Endocrinol. 2020 11 98 10.3389/fendo.2020.00098 PMC7056831 32174891 · DOI
- [24]Migda M. Migda M.S. Migda B. Krzyżanowska P. Wender-Ożegowska E. Components of metabolic syndrome in the first trimester of pregnancy as predictors of adverse perinatal outcome Ginekol. Polska 2016 87 644 650 10.5603/GP.2016.0060 27723072 · DOI
- [25]Tranidou A. Dagklis T. Tsakiridis I. Siargkas A. Apostolopoulou A. Mamopoulos A. Goulis D.G. Chourdakis M. Risk of developing metabolic syndrome after gestational diabetes mellitus—A systematic review and meta-analysis J. Endocrinol. Investig. 2021 44 1139 1149 10.1007/s40618-020-01464-6 33226626 · DOI · Paper page
Cited by
Sorted by citations
Wu, Y., Gao, Z., Gou, Y., Yan, L., & Duan, Y. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1862412
- Authors
- Bartáková, V., Chalásová, K., Pácal, L., Ťápalová, V., Máchal, J., Janků, P., & Kaňková, K.
- Affiliations
- Masaryk University (CZ)
- University Hospital Brno (CZ)
- Corresponding author
- Bartáková, Vendula
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-02-22
- Volume
- 13
- Issue
- 5
- Pages
- 1260
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC10932344
- OpenAlex
- W4392058720
- Cited by
- 6
- References
- 3
- Citations by year
- 2026: 1 · 2025: 5
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Veřejné služby Informačního systému (Masarykiana Brunensis Universitas) (submittedVersion, cc-by)
- Funders
- European Union—Next-Generation EU (LX22NPO5104)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Keywords
- metabolic syndrome, gestational diabetes mellitus, second trimester, macrosomia, Apgar score, metabolic syndrome screening, women
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review